(Q40986263)

25 September 2017

title

Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP). (English)

1 reference

25 September 2017

3

Bornstein SR

1 reference

25 September 2017

Haidan A

1

1 reference

25 September 2017

Hilbers U

series ordinal

2

1 reference

25 September 2017

Ehrhart-Bornstein M

series ordinal

4

1 reference

25 September 2017

publication date

1 January 1998

1 reference

25 September 2017

number of pages

7

1 reference

inferred from page(s)

published in

Peptides

1 reference

25 September 2017

volume

19

1 reference

25 September 2017

issue

9

1 reference

25 September 2017

page(s)

1511-1517

1 reference

Demonstration of [125I]VIP binding sites and effects of VIP on cAMP-formation in rat insulinoma (RINm5F and RIN14B) cells

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerular zone could be mediated by catecholamines via beta 1 adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Hormonal regulation of angiotensin II type 1 receptor expression and AT1-R mRNA levels in human adrenocortical cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Cellular communication in the neuro-adrenocortical axis: role of vasoactive intestinal polypeptide (VIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Role of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Neuroendocrine properties of adrenocortical cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Basal steroidogenic activity of adrenocortical cells is increased 10-fold by coculture with chromaffin cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Immunohistochemical demonstration of the synthesis enzyme for nitric oxide and of comediators in neurons and chromaffin cells of the human adrenal medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Vasoactive intestinal peptide stimulation of aldosterone secretion by the rat adrenal cortex may be mediated by the local release of catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Inhibition of human neuroblastoma growth by a specific VIP antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

ACTH induces up-regulation of ACTH receptor mRNA in mouse and human adrenocortical cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

The NCI-H295 cell line: a pluripotent model for human adrenocortical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Deletion of the Adrenocorticotropin Receptor Gene in Human Adrenocortical Tumors: Implications for Tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

The role of peptides and their receptors as tumor markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

A new neuroregulator: The vasoactive intestinal peptide or VIP

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Vasoactive intestinal polypeptide (VIP): current status

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900115-6

7 January 2021

10.1016/S0196-9781(98)00115-6

Identifiers

DOI

1 reference

25 September 2017

1 reference